Call us 24x7

24x7 Consultation

Success

x

Investor Relations

Disclosures under Regulation 46 of the SEBI (LODR) Regulations, 2015.
CORPORATE GOVERNANCE
Board of Directors
Board & Board Committees
Policies & Programs
Financials
Financials
Quarterly Results
Annual Reports
Subsidiary Financials
Investor Information
Shareholder Information
Stock Exchange Disclosures
Dividend
Listing On Stock Exchanges
Investor Contact
CORPORATE GOVERNANCE
CORPORATE GOVERNANCE
Board Of Directors
Constitution of Board & Board Committees
Policies & Programs
Financials
Financials
Quarterly Results
Annual Reports
Subsidiary Financials
Investor Information
Shareholder Information
Stock Exchange Disclosures
Dividend
Listing On Stock Exchanges
Investor Contact

Board of Directors

Dr. Ramesh Kancharla

Chairman and Managing Director

Dr. Dinesh Kumar Chirla

Whole-time Director

Mr. Aluri Srinivasa Rao

Independent Director

Dr Anil Dhawan

Independent Director

Sundari Raviprasad Pisupati

Independent Director

Mr. Santanu Mukherjee

Independent Director

Composition of Board & Board Committees

Name Designation Audit Committee Risk Management Committee Nomination & Remuneration Committee Stakeholders Relationship Committee CSR Committee
Dr. Anil Dhawan Independent Director -
Mr. Aluri Srinivasa Rao Independent Director -
Ms. Sundari R. Pisupati Independent Director -
Mr. Santanu Mukherjee Independent Director -
Dr. Ramesh Kancharla Chairman & Managing Director - -
Dr. Dinesh Kumar Chirla Whole-Time Director - - - -
Mr. R. Gowrisankar Chief Financial Officer - - - -
Mr. Mahesh Madduri Head of Strategy - - - -
img1 Chairperson
img1 Member

Letters of Appointment

Letters of Appointment issued to the following independent Directors of the company:

Quarterly Results

Results for Quarter & Year Ended June 30, 2022
  • Audio Recording Conference Call - Q1 FY23
  • Results for Quarter & Year Ended March 31, 2022
  • Earnings Call Video Recording - Q4FY22
  • Subsidiary Financials

    Material Creditors

    • As on Sept 30, 2021, the Company does not have any material creditors

    Shareholder Information

    Particulars / Financials Notice AGM Results-AGM Transcript
    2021-22

    During the Financial Year 2021-22, the Company has been assigned a credit rating of “AA-” stable by ICRA for non-convertible debentures.

    As on Sept 30, 2021, the Company does not have any material creditors

    Stock Exchange Disclosures

    Dividend

    Listing on Stock Exchanges

    The Ordinary Shares of the Company are listed on the following 2 Stock Exchanges in India:

    Name Of Stock Exchange Address Stock Codes / Symbols
    Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. 543524
    National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra East, Mumbai 400 051 RAINBOW

    Postal Ballot

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad .

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad

    For Analysts & Institutional Investors

    R Gowrisankar

    Chief Financial Officer

    Chief Financial Officer

    8-2-19/1/A, Daulet Arcade, Road No. 11,

    Banjara Hills, Hyderabad – 500 034, Telangana

    Tel: +91 40 49692244

    Email:investorrelations@rainbowhospitals.in

    Registrar & Share Transfer Agent

    KFin Technologies Private Limited

    KFin Technologies Private Limited

    Plot 31 and 32, Financial District

    Nanakramguda, Serilingampally

    Hyderabad, Rangareddi 500 032 Telangana, India

    Telephone: +91 40 6716 2222

    Website: www.kfintech.com

    Investor Grievance ID: einward.ris@kfintech.com

    Contact Person: M Murali Krishna

    Tel: +91 40 49692244

    For Investor Grievances

    Ashish Kapil

    Company Secretary & Compliance Officer

    Rainbow Children’s Medicare Limited

    8-2-19/1/A, Daulet Arcade, Road No. 11,

    Banjara Hills, Hyderabad – 500 034, Telangana

    Tel: +91 40 49692244

    Email: companysecretary@rainbowhospitals.in

    Unclaimed/Unpaid Amount

    Reports